Ecology and Medicine Converge at the Microbiome-Host Interface

Area of Science:

• Microbiology
• Host-Microbiome Interactions
• Therapeutic Development

Background:

• The human body harbors a complex microbiome crucial for health and disease.
• Current microbiome-modulating therapies (e.g., fecal microbiome transplantation, probiotics) have variable efficacy and safety profiles.
• Mechanisms of microbe-microbe interactions within the human microbiome remain poorly understood.

Purpose of the Study:

• To discuss known and potential mechanisms of inter-commensal interactions in the gut.
• To explore how these interactions can be leveraged to enhance microbiome-targeting therapeutics.
• To facilitate the clinical translation of microbiome research.

Main Methods:

• This commentary synthesizes current knowledge on microbial interactions.
• It reviews existing literature on signaling mechanisms between commensal microorganisms.
• It proposes avenues for therapeutic development based on these interactions.

Main Results:

• Several known and putative signaling mechanisms mediate interactions between gut commensals.
• Understanding these interactions is critical for predicting and controlling therapeutic outcomes.
• Targeting microbe-microbe communication offers a promising strategy for improving therapeutic efficacy and safety.

Conclusions:

• Elucidating microbe-microbe interactions is essential for advancing microbiome-based medicine.
• Harnessing these mechanisms can lead to more effective and safer microbiome therapeutics.
• Further research into inter-commensal signaling will accelerate the clinical application of microbiome interventions.